원격전이가최초증상으로발현된분화갑상선암. Differentiated Thyroid Carcinoma Presenting Distant Metastses as a Initial Sign

Similar documents
Coexistence of parathyroid adenoma and papillary thyroid carcinoma. Yong Sang Lee, Kee-Hyun Nam, Woong Youn Chung, Hang-Seok Chang, Cheong Soo Park

Changing trends in the management of well-differentiated thyroid carcinoma in Korea

Calcitonin. 1

Gerard M. Doherty, MD

Dr J K Jekel Dept. Surgery University of Pretoria

Thyroid remnant volume and Radioiodine ablation in Differentiated thyroid carcinoma.

Get The Cancer Staging Manual Pdf Thyroid

4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women

THYROID CANCER IN CHILDREN

Multi-Organ Distant Metastases in Follicular Thyroid Cancer- Rare Case Report

Adjuvant therapy for thyroid cancer

THYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine

B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.

Downloaded from journal.gums.ac.ir at 9:58 IRST on Sunday February 17th 2019

Persistent & Recurrent Differentiated Thyroid Cancer

- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer

Case 4: Disseminated bone metastases from differentiated follicular thyroid cancer

Anaplastic Thyroid Carcinoma: A Therapeutic Dilemma

American College of Radiology ACR Appropriateness Criteria

Four Cases of Malignant Pleural Effusion in Patients with Papillary Thyroid Carcinoma

Review Article Management of papillary and follicular (differentiated) thyroid carcinoma-an update

An Unexpected Cause of Hypoglycemia

Pediatric Thyroid Cancer Lung Metastases. Liora Lazar MD

Thyroid Cancer: Overview And Peculiar Aspects In Philippines Nemencio A. Nicodemus Jr., MD

ORIGINAL ARTICLE. Management and Outcome of Recurrent Well-Differentiated Thyroid Carcinoma

Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy

Yonsei Experience of 5000 Gasless Transaxillary Robotic Thyroidectomies

Case 5: Thyroid cancer in 42 yr-old woman with Graves disease

유두상갑상선암종에서경부림프절전이의양상및치료

Locally advanced papillary thyroid cancer

Differentiation of Thyroid Nodules With Macrocalcifications

Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules

Index. Surg Oncol Clin N Am 15 (2006) Note: Page numbers of article titles are in boldface type.

Reoperative central neck surgery

Differentiated Thyroid Cancer: Initial Management

Oral Presentation V. Surgical Outcome of Atypia of Undetermined Significance and Follicular Lesion of Undetermined Significance in Thyroid Nodule

Papillary Thyroid Carcinoma with Retropharyngeal Node Metastasis Demonstrating Negative I-131 but Positive FDG Uptake on PET/CT

131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans

Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD

Thyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.

10/24/2008. Surgery for Well-differentiated Thyroid Carcinoma- The Primary

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid

Case 4 Diagnosis 2/21/2011 TGB

Department of Surgery, Eulji University College of Medicine, Seoul, Republic of Korea 2

2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines

Biomedical Research 2017; 28 (21): ISSN X

Initial surgery for differentiated thyroid cancer: What is the appropriate extent and attendant risks and benefits?

Anca M. Avram, M.D. Professor of Radiology

Differentiated Thyroid Carcinoma of Children and Adolescents: 27-Year Experience in the Yonsei University Health System

Is Hepatic Resection Needed in the Patients with Peritoneal Side T2 Gallbladder Cancer?

Radionuclide Therapy. Prof. Dr. Çetin Önsel. Cerrahpaşa Medical School Department of Nuclear Medicine. Radionuclide Therapy

Management of Thyroid Nodules

A Review of Differentiated Thyroid Cancer

Quality of life (QoL) in metastatic breast cancer patients with. maintenance paclitaxel plus gemcitabine (PG) chemotherapy:

What is Thyroid Cancer? Here are four types of thyroid cancer:

Tania Kaprealian, M.D. Assistant Professor UCLA Department of Radiation Oncology August 22, 2015

International Czech and Slovak cooperation in the treatment of patients with differentiated thyroid cancer

Endocr. J./ T. S. JUNG et al.: POORLY DIFFERENTIATED THYROID CARCINOMA doi: /endocrj.K06-166

Solitary lateral neck node metastasis in papillary thyroid carcinoma

Metastatic papillary thyroid cancers with malignant pleural effusion aggravated during thyroid hormone withdrawal for radioiodine therapy

Correspondence should be addressed to Stan H. M. Van Uum;

Childhood and Adolescent Thyroid Carcinoma

Dr Catherine Woolnough, Hospital Scientist, Chemical Pathology, Royal Prince Alfred Hospital. NSW Health Pathology University of Sydney

Surgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries

A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study

RESEARCH ARTICLE. Comparison of Presentation and Clinical Outcome between Children and Young Adults with Differentiated Thyroid Cancer

Disclosures Nodal Management in Differentiated Thyroid Carcinoma

Thyroid Pathology: It starts and ends with the gross. Causes of Thyrophobia. Agenda. Diagnostic ambiguity. Treatment/prognosis disconnect

Distant and Lymph Node Metastases of Thyroid Nodules with No Pathological Evidence of Malignancy: A Limitation of Pathological Examination

Objectives. 1)To recall thyroid nodule ultrasound characteristics that increase the risk of malignancy

PEDIATRIC Ariel Katz MD

PAPER. Predicting Outcome and Directing Therapy for Papillary Thyroid Carcinoma

INTRODUCTION. Tae Yong Park, Young Chul Na, Won Hee Lee, Ji Hee Kim, Won Seok Chang, Hyun Ho Jung, Jong Hee Chang, Jin Woo Chang, Young Gou Park

Differentiated Thyroid Cancer: Reclassification of the Risk of Recurrence Based on the Response to Initial Treatment

Medicine. Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer

Skull metastasis of follicular thyroid carcinoma: a rare case report

Chirurgie beim oligo-metastatischen NSCLC

Case Report Durable Effect of Radioactive Iodine in a Patient with Metastatic Follicular Thyroid Carcinoma

Nicolae Bacalbasa Carol Davila University Of Medicine and Pharmacy

Evaluation and Management of Thyroid Nodules. Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada

SARDA AND OTHERS No. of patients (%) Figure 1. Age distribution. Papillary Follicular < > 60 Age at chagnos

Mandana Moosavi 1 and Stuart Kreisman Background

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer

Predictors and Patterns of recurrence after radical surgery in ampulla of vater cancer: Comparison analysis between early and late recu rrence.

OLGU SUNUMU. Dr. Erdal Taşçı

Carcinoma of thyroid - clinical presentation and outcome

Correlation analyses of thyroid-stimulating hormone and thyroid autoantibodies with differentiated thyroid cancer

Prognostic Factors for Well Differentiated Thyroid Cancer in an Endemic Area

Success rate of thyroid remnant ablation for differentiated thyroid cancer based on 5550 MBq post-therapy scan

Gamma Knife Surgery for Brain Metastasis from Renal Cell Carcinoma : Relationship Between Radiological Characteristics and Initial Tumor Response

Management guideline for patients with differentiated thyroid cancer. Teeraporn Ratanaanekchai ENT, KKU 17 October 2007

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer

Tumor Margin Histology Predicts Tumor Aggressiveness in Papillary Thyroid Carcinoma: A Study of 514 Consecutive Patients

9 year-old Female with Papillary Thyroid Cancer. Katie O Sullivan, M.D. Fellow Medicine/Pediatric Endocrinology Thursday, January 16 th, 2014

Case Scenario 1: Thyroid

Review Article Management of thyroid carcinoma Alauddin M, Joarder AH

Treatment Results and Prognostic Factors of Early Breast Cancer Treated with a Breast Conserving Operation and Radiotherapy

Radiation Therapy for Thyroid Cancer. When is Radiation Therapy indicated in Thyroid Cancer of Follicular or Parafollicular Cell Origin?

Transcription:

원격전이가최초증상으로발현된분화갑상선암 Differentiated Thyroid Carcinoma Presenting Distant Metastses as a Initial Sign Jandee Lee, M.D., Kee-Hyun Nam, M.D., Chi-Young Lim, M.D., Woong Youn Chung, M.D. and Cheong Soo Park, M.D. Purpose: Distant metastases, as the initial sign of a differentiated thyroid carcinoma, are extremely rare. The clinical characteristics for such cases remain to be established. This study was performed to characterize the clinical presentation, treatments, and outcome in such patients. Methods: Between January 1986 and February 2005, of 4,525 differentiated thyroid cancer patients, 18 presented with distant metastases as the initial sign (0.4%). These comprised of 6 men and 12 women, with a median age of 49 years (range 9 66). Of the 18 patients, 8 (44.4%), 7 (38.9%), and 3 (16.7%) disclosed symptoms from lung, bone, and brain (16.7%) metastases, respectively. The median follow-up was 92 months, ranging from 18 to 198. Results: The symptoms included cough and sputum (n=5), hemoptysis (n=2) and a lung mass (n=1) from lung metastases, back pain (n=3), a palpable mass (n=2) and a pathologic fracture (n=2) from bone metastases, as well as a headache with nausea (n=3) in all cases with brain metastases. The sites of metastases were the lung only in 7 (38.9%), bone only in 7 (38.9%) and multi-organ in 4 (22.2%). The histological diagnoses were a papillary carcinoma in 10 and a follicular carcinoma in 8. All patients underwent a total thyroidectomy followed by therapeutic radio-iodine therapy (RAI) and TSH suppressive treatment. For the metastatic lesions, aggressive treatment modalities, including surgical resection (n=9), external beam radiation (n=11), gamma-knife surgery (n=1) and a combination of these, were performed. The 10 year overall and disease-free survivals were 91.7 and 51.4%, respectively. There was only one disease-related death (1.6%). Tumor multiplicity (p=0.023) and multi-organ metastasis (p=0.009) were significant predictors of a poor prognosis. Conclusion: Clinical symptoms, history, physical examination, imaging studies and histological confirmation of distant metastatic lesions are important in the initial diagnostic approach. Even though distant metastasis presented as the initial sign, a 10-year disease-free survival rate of 50% was obtained. Radical resection of primary and metastatic lesions combined with high dose RAI treatment and/or external irradiation lead to long-term survival. (J Korean Surg Soc 2006;71:105-111) Key Words: Distant metastasis, Initial sign, Differentiated thyroid carcinoma :,, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea

Book: Journal Cat: Original Extra: No: Jkss071-02-05 Issn: 1226-0053 Vol: 071 Num: 02 Regnum: 05 StartPage: 105 LastPage: 111 TotPage: 7 HSubject: 원격전이가최초증상으로발현된분화갑상선암 ESubject: Differentiated Thyroid Carcinoma Presenting Distant Metastses as a Initial Sign HAuthor: 이잔디 남기현 임치영 정웅윤 박정수 EAuthor: Jandee Lee, M.D., Kee-Hyun Nam, M.D., Chi-Young Lim, M.D., Woong Youn Chung, M.D. and Cheong Soo Park, M.D. HmainAuthor: 박정수 EmainAuthor: Cheong Soo Park HPlace: 연세대학교의과대학외과학교실 EPlace: Department of Surgery, Yonsei University College of Medicine, Seoul, Korea HPublisher: 대한외과학회 EPublisher: J Korean surgical society Publisher_date: 2006-07-30 HAbstract: EAbstract: Purpose: Distant metastases, as the initial sign of a differentiated thyroid carcinoma, are extremely rare. The clinical characteristics for such cases remain to be established. This study was performed to characterize the clinical presentation, treatments, and outcome in such patients. Methods: Between January 1986 and February 2005, of 4,525 differentiated thyroid cancer patients, 18 presented with distant metastases as the initial sign (0.4%). These comprised of 6 men and 12 women, with a median age of 49 years (range 9~66). Of the 18 patients, 8 (44.4%), 7 (38.9%), and 3 (16.7%) disclosed symptoms from lung, bone, and brain (16.7%) metastases, respectively. The median follow-up was 92 months, ranging from 18 to 198. Results: The symptoms included cough and sputum (n=5), hemoptysis (n=2) and a lung mass (n=1) from lung metastases, back pain (n=3), a palpable mass (n=2) and a pathologic fracture (n=2) from bone metastases, as well as a headache with nausea (n=3) in all cases with brain metastases. The sites of metastases were the lung only in 7 (38.9%), bone only in 7 (38.9%) and multi-organ in 4 (22.2%). The histological diagnoses were a papillary carcinoma in 10 and a follicular carcinoma in 8. All patients underwent a total thyroidectomy followed by therapeutic radio-iodine therapy (RAI) and TSH suppressive treatment. For the metastatic lesions, aggressive treatment modalities, including surgical resection (n=9), external beam radiation (n=11), gamma-knife surgery (n=1) and a combination of these, were performed. The 10 year overall and disease-free survivals were 91.7 and 51.4%, respectively. There was only one disease-related death (1.6%). Tumor multiplicity (p=0.023) and multi-organ metastasis (p=0.009) were significant predictors of a poor prognosis. Conclusion: Clinical symptoms, history, physical examination, imaging studies and histological confirmation of distant metastatic lesions are important in the initial diagnostic approach. Even though distant metastasis presented as the initial sign, a 10-year disease-free survival rate of 50% was obtained. Radical

resection of primary and metastatic lesions combined with high dose RAI treatment and/or external irradiation lead to long-term survival. (J Korean Surg Soc 2006;71:105-111) HKeywords: 원격전이, 최초임상증상, 분화갑상선암 EKeywords: Distant metastasis, Initial sign, Differentiated thyroid carcinoma File_name: Jkss071-02-05.pdf